According to an ANA report, Zahra Alikhani has patented the ‘Nano vaccine candidate against Pseudomonas aeruginosa’ which is now awaiting review for registration at the US Patent Office.
Pseudomonas infection is caused by strains of bacteria found widely in the environment; the most common type causing infections in humans is called Pseudomonas aeruginosa. Serious Pseudomonas infections usually occur in people in the hospital and/or with weakened immune systems. Infections of the blood, pneumonia, and infections following surgery can lead to severe illness and death in these people.
The supervisor of this project, Dr. Mojtaba Salouti, stated that due to the interesting results achieved regarding the effectiveness of the vaccine in mice, researches will be continuing to adapt and make it usable for humans.
The international exposition of inventions is annually held under direct intellectual property of World Intellectual Property Organization (WIPO) and it is sponsored by International Federation of Inventor’s Association in different countries in South Korea and a number of 120 inventions from 20 countries were introduced.